| Date Filed | Type | Description |
| 10/11/2023 |
144
| Form 144 - Report of proposed sale of securities: |
| 10/05/2023 |
144
| Form 144 - Report of proposed sale of securities: |
| 08/25/2023 |
4
| Schuth Alexander O. (COFO and Secretary) has filed a Form 4 on Denali Therapeutics Inc.|
Txns:
| Sold 2,522 shares
@ $23.17, valued at
$58.4k
|
|
| 08/25/2023 |
4
| Ho Carole (Chief Medical Officer) has filed a Form 4 on Denali Therapeutics Inc.|
Txns:
| Sold 2,522 shares
@ $23.22, valued at
$58.6k
|
|
| 08/23/2023 |
4
| Ho Carole (Chief Medical Officer) has filed a Form 4 on Denali Therapeutics Inc.|
Txns:
| Sold 2,478 shares
@ $22.6, valued at
$56k
|
|
| 08/23/2023 |
4
| Schuth Alexander O. (COFO and Secretary) has filed a Form 4 on Denali Therapeutics Inc.|
Txns:
| Sold 2,478 shares
@ $22.59, valued at
$56k
|
|
| 08/23/2023 |
4
| Watts Ryan J. (President and CEO) has filed a Form 4 on Denali Therapeutics Inc.|
Txns:
| Sold 2,309 shares
@ $22.59, valued at
$52.2k
|
|
| 08/23/2023 |
4
| Krognes Steve E. (Director) has filed a Form 4 on Denali Therapeutics Inc.|
Txns:
| Sold 1,419 shares
@ $22.6, valued at
$32.1k
|
|
| 08/23/2023 |
144
| Form 144 - Report of proposed sale of securities: |
| 08/23/2023 |
144
| Form 144 - Report of proposed sale of securities: |
| 08/21/2023 |
8-K
| Entry into a Material Definitive Agreement Interactive Data |
| 08/21/2023 |
144
| Form 144 - Report of proposed sale of securities: |
| 08/21/2023 |
144
| Form 144 - Report of proposed sale of securities: |
| 08/21/2023 |
144
| Form 144 - Report of proposed sale of securities: |
| 08/21/2023 |
144
| Form 144 - Report of proposed sale of securities: |
| 08/17/2023 |
4
| SATO VICKI L (Director) has filed a Form 4 on Denali Therapeutics Inc.|
Txns:
| Sold 1,666 shares
@ $24.3, valued at
$40.5k
|
|
| 08/16/2023 |
4
| Ho Carole (Chief Medical Officer) has filed a Form 4 on Denali Therapeutics Inc.|
Txns:
| Sold 2,768 shares
@ $23.79, valued at
$65.9k
|
|
| 08/16/2023 |
4
| Schuth Alexander O. (COFO and Secretary) has filed a Form 4 on Denali Therapeutics Inc.|
Txns:
| Sold 2,772 shares
@ $23.67, valued at
$65.6k
|
|
| 08/15/2023 |
144
| Form 144 - Report of proposed sale of securities: |
| 08/14/2023 |
4
| Watts Ryan J. (President and CEO) has filed a Form 4 on Denali Therapeutics Inc.|
Txns:
| Exercised 2,526 shares
@ $0.68, valued at
$1.7k
Sold 2,526 shares
@ $25.03, valued at
$63.2k
Exercised 2,526 options to buy
@ $0.68, valued at
$1.7k
|
|
| 08/14/2023 |
4
| Ho Carole (Chief Medical Officer) has filed a Form 4 on Denali Therapeutics Inc.|
Txns:
| Sold 2,857 shares
@ $24.15, valued at
$69k
|
|
| 08/14/2023 |
4
| Schuth Alexander O. (COFO and Secretary) has filed a Form 4 on Denali Therapeutics Inc.|
Txns:
| Sold 2,853 shares
@ $24.18, valued at
$69k
|
|
| 08/14/2023 |
144
| Form 144 - Report of proposed sale of securities: |
| 08/14/2023 |
144
| Form 144 - Report of proposed sale of securities: |
| 08/10/2023 |
144
| Form 144 - Report of proposed sale of securities: |
| 08/10/2023 |
144
| Form 144 - Report of proposed sale of securities: |
| 08/10/2023 |
144
| Form 144 - Report of proposed sale of securities: |
| 08/08/2023 |
10-Q
| Quarterly Report for the period ended June 30, 2023 |
| 08/08/2023 |
8-K
| Quarterly results |
| 07/19/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 07/19/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 07/18/2023 |
144
| Form 144 - Report of proposed sale of securities: |
| 07/17/2023 |
144
| Form 144 - Report of proposed sale of securities: |
| 06/30/2023 |
4
| SATO VICKI L (Director) has filed a Form 4 on Denali Therapeutics Inc.|
Txns:
| Sold 552 shares
@ $29.55, valued at
$16.3k
Sold 1,114 shares
@ $29.98, valued at
$33.4k
|
|
|